Brazil vs Colombia: Memorandum items, Financial derivatives (net marked to market)

Brazil
1.54 billion
in 2025
Colombia
9.32 billion
in 2025
Brazil rank
3rd
Colombia rank
1st

Memorandum items, Financial derivatives (net marked to market) over time

  • Brazil
  • Colombia
-2.5B02.5B5.0B7.5B10.0B200020122025

How they compare

Colombia currently reports 9.32 billion against 1.54 billion in Brazil, a difference of 7.78 billion.

That makes Colombia's figure about 6.0 times Brazil's.

The two have swapped places 10 times across 20 shared years of data; in 2006 it was Colombia ahead.

Brazil ranks 3rd and Colombia ranks 1st of 53 countries.

Across the 3 decades both report, Brazil averaged higher in 2 and Colombia in 1.

Head to head by decade

Decade Brazil Colombia Difference Ahead
2000s 98.19 million 34.41 million 63.78 million Brazil
2010s 54.13 million 0 54.13 million Brazil
2020s 364.24 million 1.55 billion 1.19 billion Colombia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher memorandum items, financial derivatives (net marked to market), Brazil or Colombia?
Colombia, at 9.32 billion against 1.54 billion in Brazil as of 2025.
What is the difference in memorandum items, financial derivatives (net marked to market) between Brazil and Colombia?
7.78 billion, with Colombia ahead.
How many years of comparable data are there for Brazil and Colombia?
20 years are reported by both, from 2006 to 2025.
How do Brazil and Colombia rank globally for memorandum items, financial derivatives (net marked to market)?
Brazil ranks 3rd and Colombia ranks 1st of 53 countries.
Where does this data come from?
International Monetary Fund, published as Memorandum items, Financial derivatives (net marked to market), swaps, Assets (International Reserves and Foreign Currency Liquidity: Guidelines for a Data Template 2013 (IRFCL 2013), Monetary Authorities and Central Government excluding Social Security). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Brazil vs Colombia: Memorandum items, Financial derivatives (net marked to market). Statizoid, drawing on International Monetary Fund. Retrieved 15 September 2026, from https://financial-sector.statizoid.com/compare/memorandum-items-financial-derivatives-net-marked-to-market-swaps-assets-international/brazil/colombia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under IMF Terms and Conditions (attribution required); please keep the attribution.

<a href="https://financial-sector.statizoid.com/compare/memorandum-items-financial-derivatives-net-marked-to-market-swaps-assets-international/brazil/colombia/">Brazil vs Colombia: Memorandum items, Financial derivatives (net marked to market)</a> — Statizoid

About this data

Indicator
Memorandum items, Financial derivatives (net marked to market), swaps, Assets (International Reserves and Foreign Currency Liquidity: Guidelines for a Data Template 2013 (IRFCL 2013), Monetary Authorities and Central Government excluding Social Security)
Source
International Monetary Fund
Licence
IMF Terms and Conditions (attribution required)
Coverage
55 places, 1,034 data points, 1999–2025
Last refreshed

The International Reserves and Foreign Currency Liquidity (IRFCL, or the “Reserves Data Template”) dataset includes data on the amount and composition of countries’ official reserve assets, other foreign currency assets held by monetary authorities and central governments, and short-term foreign currency obligations and related activities of monetary authorities and central governments that can lead to drains on official reserves and other foreign currency assets. This website re-disseminates IMF member countries' data on international reserves and foreign currency liquidity in a common template and in a common currency (the U.S. dollar). Historical data by country are also available. Please note that the re-dissemination of the template data by the Fund does not constitute endorsement of the quality of the data by the Fund.